LGALS3 and COVID-19: Moreover, galectins were proved to activate the pro-inflammatory transcription factor N-f-kB and to induce the release of IL-6 and TNF-a [49]; in addition, an increasing number of patients suffering from COVID-19 showed highly elevated levels of gal-3 together with the so-called “cytokine storm syndrome” (CSS).